3Yusuf S,HaWKens,Upaus,et al.Okesity and the risk of myocardial infarction in 27.000 participants from 52 countries,a case-controlled study[J].Lanc et,2005,366(9497):1640-1649.
5[1]Schwartz GG, Olsson AG, Ezekowitz M, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial [J]. JAMA, 2001, 285(13):1711-1718.
6[2]Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis [J]. Circulation, 2002, 105(9):1135-1143.
7[3]Kinlay S, Selwyn AP. Effects of statins on inflammation in patients with acute and chronic coronary syndromes[J]. Am J Cardiol, 2003,91(4A):9B-13B.
8[4]Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inlammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization [J]. Circulation, 2001, 103(7):926-933.
9[5]Kinlay S, Timms T, Clark M, et al. Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia[J]. Am J Cardiol, 2002, 89(10):1205-1207.
10[6]Plenge JK, Hernandez TL, Weil KM, et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction[J]. Circulation, 2002, 106(12): 1447-1452.
1Fang MC,Singer DE.Anticoagulation for atrial fibrillation[J].Cardiol Clin,2004,22(1):47-62.
2Lee WJ,Smith AD,Cubelli V,et al.Complications of percutaneous nephrolithotomy[J].AJR,1987,148(4):177-180.
3Denstedt JD,Razvi HA,Rowe E,et al.Investigation of the tissue ef-fects of a new device for intracorporeal lithotripsy-the Swisslitho-clast[J].J Urol,1995,153:535-537.
